FI55186C - Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1 4-dihydropyridinkarboxylsyraestrar - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1 4-dihydropyridinkarboxylsyraestrar

Info

Publication number
FI55186C
FI55186C FI946/72A FI94672A FI55186C FI 55186 C FI55186 C FI 55186C FI 946/72 A FI946/72 A FI 946/72A FI 94672 A FI94672 A FI 94672A FI 55186 C FI55186 C FI 55186C
Authority
FI
Finland
Prior art keywords
osymmetriska
dihydropyridinkarboxylsyraestrar
foerfarande foer
foer framstaellning
terapeutiskt anvaendbara
Prior art date
Application number
FI946/72A
Other languages
English (en)
Finnish (fi)
Other versions
FI55186B (fi
Inventor
Horst Meyer
Friedrich Bossert
Wulf Vater
Kurt Stoepel
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5804433&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI55186(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI55186B publication Critical patent/FI55186B/fi
Application granted granted Critical
Publication of FI55186C publication Critical patent/FI55186C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00—Compounds containing azido groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring (AREA)
FI946/72A 1971-04-10 1972-04-06 Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1 4-dihydropyridinkarboxylsyraestrar FI55186C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2117571A DE2117571C3 (de) 1971-04-10 1971-04-10 Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Publications (2)

Publication Number Publication Date
FI55186B FI55186B (fi) 1979-02-28
FI55186C true FI55186C (fi) 1979-06-11

Family

ID=5804433

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946/72A FI55186C (fi) 1971-04-10 1972-04-06 Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1 4-dihydropyridinkarboxylsyraestrar

Country Status (27)

Country Link
US (1) US3799934A (xx)
JP (1) JPS5529989B1 (xx)
AT (1) AT316551B (xx)
AU (1) AU464663B2 (xx)
BE (1) BE781878A (xx)
BG (1) BG22818A3 (xx)
CA (1) CA921035A (xx)
CH (1) CH567472A5 (xx)
CS (1) CS175429B2 (xx)
DD (2) DD99371A5 (xx)
DE (1) DE2117571C3 (xx)
DK (1) DK132496C (xx)
ES (1) ES401614A1 (xx)
FI (1) FI55186C (xx)
FR (1) FR2132830B1 (xx)
GB (1) GB1358951A (xx)
HK (1) HK18877A (xx)
HU (1) HU164705B (xx)
IE (1) IE36265B1 (xx)
IL (1) IL39171A (xx)
LU (1) LU65138A1 (xx)
NL (1) NL164031C (xx)
NO (1) NO135589C (xx)
PL (1) PL84499B1 (xx)
RO (2) RO60479A (xx)
SE (1) SE371823B (xx)
ZA (1) ZA722348B (xx)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2210674C3 (de) * 1972-03-06 1981-09-24 Bayer Ag, 5090 Leverkusen 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
US3917622A (en) * 1972-03-06 1975-11-04 Bayer Ag 2-Amino-1,4-dihydropyridine derivatives
US4001258A (en) * 1972-03-06 1977-01-04 Bayer Aktiengesellschaft 2-amino-1,4-dihydropyridine derivatives
US3919246A (en) * 1972-03-06 1975-11-11 Bayer Ag Process for preparing 2-amino-1,4-dihydropyridine derivates
DD106832A5 (xx) * 1972-03-06 1974-07-05
US3935223A (en) * 1972-03-06 1976-01-27 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
US3917619A (en) * 1972-03-06 1975-11-04 Bayer Ag 2-Amino-4,5-dihydropyridine derivatives
DE2218644C3 (de) * 1972-04-18 1982-08-19 Bayer Ag, 5090 Leverkusen Basische Ester von 1,4-Dihydropyridinen, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3989708A (en) * 1972-08-31 1976-11-02 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2242786A1 (de) * 1972-08-31 1974-03-14 Bayer Ag Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel
DE2248150A1 (de) * 1972-09-30 1974-04-04 Bayer Ag Dihydropyridinpolyester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
CH607848A5 (xx) * 1974-06-04 1978-11-30 Bayer Ag
DE2508181A1 (de) * 1975-02-26 1976-09-09 Bayer Ag 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
FR2320750A1 (fr) * 1975-08-12 1977-03-11 Hexachimie Dihydro-1,4 pyridines et leur application therapeutique
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2650013C3 (de) * 1976-10-30 1981-04-02 Bayer Ag, 5090 Leverkusen 1.4-Dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsäureisopropyl-(2-propoxy-äthyl)-ester, Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE2658183A1 (de) * 1976-12-22 1978-07-06 Bayer Ag In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS55301A (en) * 1978-02-14 1980-01-05 Yamanouchi Pharmaceut Co Ltd 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE2837477A1 (de) * 1978-08-28 1980-03-13 Bayer Ag Sila-substituierte 1,4-dihydropyridin- derivate
DE2841667A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Fluorhaltige 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
DE2927933A1 (de) * 1979-07-11 1981-02-05 Hoechst Ag Acetylacetoxyalkyl-allyl-ether, ihre herstellung und verwendung
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE3023820A1 (de) * 1980-06-25 1982-01-14 Bayer Ag, 5090 Leverkusen 4,4-disubstituierte spiro-1,4-dihydropyridine, ein verfahren zu ihrer herstellung, sowie ihre verwendung als zwischenprodukt
DE3042769A1 (de) * 1980-11-13 1982-06-09 Bayer Ag, 5090 Leverkusen C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
US4321384A (en) * 1981-02-27 1982-03-23 American Home Products Corporation Antihypertensive agents
US4365063A (en) * 1981-08-31 1982-12-21 American Home Products Corporation Antihypertensive agents
DE3130041A1 (de) * 1981-07-30 1983-02-17 Bayer Ag, 5090 Leverkusen Dihydropyridine mit positiv inotroper wirkung, neue verbindungen, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
MX7567E (es) * 1981-12-23 1989-10-27 Yamanouchi Pharma Co Ltd Procedimiento para recubrir nicardipina de accion prolongada
JPS58159490A (ja) * 1982-02-23 1983-09-21 Nikken Kagaku Kk １，４−ジヒドロピリジン化合物
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3212736A1 (de) * 1982-04-06 1983-10-13 Bayer Ag, 5090 Leverkusen Verwendung von dihydropyridinen in arzneimitteln mit salidiuretischer wirkung
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
DE3248548A1 (de) * 1982-12-29 1984-07-05 Heinrich Mack Nachf., 7918 Illertissen Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3316510A1 (de) * 1983-05-06 1984-11-08 Bayer Ag Parenterale formulierung von nimodipin, ein verfahren zu ihrer herstellung sowie ihre verwendung bei der bekaempfung von erkrankungen
GB8314744D0 (en) * 1983-05-27 1983-07-06 Fujisawa Pharmaceutical Co 2 6-disubstituted-1 4-dihydropyridine derivative
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
DE3419128A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinpraeparate und verfahren zu ihrer herstellung
DE3419131A1 (de) * 1984-05-23 1985-11-28 Bayer Ag, 5090 Leverkusen Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
US4794111A (en) * 1984-05-23 1988-12-27 Bayer Aktiengesellschaft Dihydropyridine preparations containing β-blockers
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
DE3542794A1 (de) * 1985-12-04 1987-06-11 Bayer Ag Antihypertensives kombinationspraeparat
US4771057A (en) * 1986-02-03 1988-09-13 University Of Alberta Reduced pyridyl derivatives with cardiovascular regulating properties
US4758669A (en) * 1986-05-05 1988-07-19 Radiation Oncology Center Research And Development Corporation 4-(nitrone aryl) dihydropyridines
EP0311053A3 (en) * 1987-10-06 1991-05-08 Banyu Pharmaceutical Co., Ltd. Ameliorant of cerebral circulation and optical isomer of nb-818, processes for its production and its use
DE3741540A1 (de) * 1987-12-08 1989-06-22 Bayer Ag Verfahren zur herstellung von unsymmetrischen dihydropyridinen
US5571827A (en) * 1990-03-13 1996-11-05 Sepracor Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
DE4011105A1 (de) * 1990-04-06 1991-10-10 Bayer Ag Neue 4-chinolyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5204472A (en) * 1990-04-06 1993-04-20 Bayer Aktiengesellschaft Quinoline and isoquinoline intermediates
JPH0458703A (ja) * 1990-06-25 1992-02-25 Mitsubishi Electric Corp 引出形遮断器の導体固定装置
DE4134760A1 (de) * 1991-10-22 1993-07-08 Bayer Ag Aryl-chinolyl-substituierte 1,4-dihydropyridin-dicarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US6735990B1 (en) * 1992-01-24 2004-05-18 Acco Brands, Inc. Computer physical security device
EP0663822A4 (en) * 1992-10-06 1997-04-23 Sepracor Inc METHODS AND COMPOSITIONS FOR TREATING HYPERTENSON, ANGINES AND OTHER CONDITIONS USING OPTICALLY PURE NITREDIPINE S (-).
US6001857A (en) * 1992-10-30 1999-12-14 Bayer Aktiengesellschaft Heterocyclyl substituted dihydropyridines
DE4236707A1 (de) * 1992-10-30 1994-05-05 Bayer Ag 4-Heterocyclyl substituierte Dihydropyridine
SE9303657D0 (sv) * 1993-11-05 1993-11-05 Astra Ab Short-acting dihydropyridines
DE59410255D1 (de) * 1993-12-10 2003-04-17 Bayer Ag Phenyl-substituierte 1,4-Dihydropyridine mit cerebraler Aktivität
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
ATE548351T1 (de) * 1996-01-29 2012-03-15 Us Of America Represented By The Secretary Dept Of Health And Human Services Dihydropyridin-pyridin-, benzopyranon- und triazolochinazolin-derivate, deren herstellung und verwendung als adenosinrezeptor-antagonisten
DE19727350C1 (de) * 1997-06-27 1999-01-21 Bayer Ag Verfahren zur Herstellung von Nifedipin
WO1999025347A2 (en) 1997-11-14 1999-05-27 Neurosearch A/S Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
AU4688301A (en) * 2000-04-11 2001-10-23 Sankyo Co Stabilized pharmaceutical compositions containing calcium channel blockers
US6653481B2 (en) * 2000-12-29 2003-11-25 Synthon Bv Process for making amlodipine
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
AU2005269465A1 (en) * 2004-07-26 2006-02-09 Cotherix, Inc. Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
ATE551059T1 (de) * 2005-10-26 2012-04-15 Asahi Kasei Pharma Corp Fasudil in kombination mit bosentan zur behandlung von pulmonaler arterieller hypertonie
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
TW200806648A (en) * 2005-11-29 2008-02-01 Sankyo Co Acid addition salts of dihydropyridine derivatives
TW200736245A (en) * 2005-11-29 2007-10-01 Sankyo Co Acid addition salts of optically active dihydropyridine derivatives
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2012037665A1 (en) 2010-09-24 2012-03-29 Oral Delivery Technology Ltd. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
US9399019B2 (en) 2012-05-09 2016-07-26 Evonik Corporation Polymorph compositions, methods of making, and uses thereof
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA3040914A1 (en) 2016-11-03 2018-05-24 Juno Therapeutics, Inc. Combination therapy of a cell based therapy and a microglia inhibitor
EP3631468A1 (en) 2017-06-02 2020-04-08 Juno Therapeutics, Inc. Articles of manufacture and methods related to toxicity associated with cell therapy
EP3630132A1 (en) 2017-06-02 2020-04-08 Juno Therapeutics, Inc. Articles of manufacture and methods for treatment using adoptive cell therapy
US20210071258A1 (en) 2017-09-01 2021-03-11 Juno Therapeutics, Inc. Gene expression and assessment of risk of developing toxicity following cell therapy
WO2019089848A1 (en) 2017-11-01 2019-05-09 Juno Therapeutics, Inc. Methods associated with tumor burden for assessing response to a cell therapy
SG11202105502RA (en) 2018-11-30 2021-06-29 Juno Therapeutics Inc Methods for treatment using adoptive cell therapy
PT3886894T (pt) 2018-11-30 2024-05-02 Juno Therapeutics Inc Métodos para dosagem e tratamento de malignidades de células b em terapia celular adotiva
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof
AU2020395318A1 (en) 2019-12-06 2022-06-09 Juno Therapeutics, Inc. Methods related to toxicity and response associated with cell therapy for treating B cell malignancies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2359329A (en) * 1943-06-18 1944-10-03 Burroughs Wellcome Co Quinoline substituted dihydropyridines
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern

Also Published As

Publication number Publication date
NO135589B (xx) 1977-01-17
IL39171A0 (en) 1972-07-26
JPS5529989B1 (xx) 1980-08-07
DE2117571C3 (de) 1979-10-11
IE36265B1 (en) 1976-09-29
CH567472A5 (xx) 1975-10-15
BG22818A3 (bg) 1977-04-20
RO60479A (xx) 1976-08-15
DD102077A5 (xx) 1973-12-05
DK132496C (da) 1976-05-24
GB1358951A (en) 1974-07-03
NL7204693A (xx) 1972-10-12
FI55186B (fi) 1979-02-28
DK132496B (da) 1975-12-15
DE2117571B2 (de) 1979-01-11
BE781878A (fr) 1972-10-10
DD99371A5 (xx) 1973-08-05
NL164031B (nl) 1980-06-16
HU164705B (xx) 1974-04-11
ES401614A1 (es) 1975-11-01
FR2132830A1 (xx) 1972-11-24
SU435612A3 (ru) 1974-07-05
SE371823B (xx) 1974-12-02
NL164031C (nl) 1980-11-17
AT316551B (de) 1974-07-25
CA921035A (en) 1973-02-13
US3799934A (en) 1974-03-26
IE36265L (en) 1972-10-10
NO135589C (xx) 1977-04-27
AU4045572A (en) 1973-10-04
LU65138A1 (xx) 1972-07-12
RO62643A (fr) 1978-05-15
DE2117571A1 (de) 1972-10-19
PL84499B1 (xx) 1976-04-30
FR2132830B1 (xx) 1975-12-26
IL39171A (en) 1975-04-25
HK18877A (en) 1977-04-29
CS175429B2 (xx) 1977-05-31
AU464663B2 (en) 1975-08-18
ZA722348B (en) 1972-12-27

Similar Documents

Publication Publication Date Title
FI55186C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara osymmetriska 1 4-dihydropyridinkarboxylsyraestrar
FI53919C (fi) Laekemedelsbaerare av silikongummi
FI54299C (fi) Foerfarande foer framstaellning av saosom maskmedel verksamma 2-karbalkoxiaminobensimidazol-5(6)-fenyletrar
FI55072C (fi) Sammansatt ljudisoleringsfodring saerskilt foer fodring av mellanvaeggar
FI54323C (fi) Foerfarande foer framstaellning av foertyngningsaemnen foer spolmedel foer borrhaol
FI54027C (fi) Vaermevaexlare av avdunstningstyp
FI55171B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-fenoxifenoxialkankarbonsyraderivat
FI54623C (fi) Foerfarande foer vaotoxidering av svartlut fraon alkalisk kokningsprocess
FI54146B (fi) Foerfarande foer framstaellning av en koncentrerad laktulossirap
FI54041C (fi) Foerfarande foer framstaellning av en aromanrikad kaffeprodukt
FI53736C (fi) Platta foer skydd av grundmur
FI54851B (fi) Foerfarande foer framstaellning av aetbar flerskiktsprodukt
FI54305B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva isoindolinderivat
FI55210C (fi) Foerfarande foer hydrokrackning av asfaltenhaltiga kolvaeten
IT967203B (it) 2 aminochinossaline
FI55047C (fi) Foerfarande foer reformering av en bensinfraktion
FI46484B (fi) Av plastfolie framstaelld baerkasse
FI54705B (fi) Foerfarande foer framstaellning av arylalkylpyrrylaminoetanol
FI53702C (fi) Foerfarande foer framstaellning av isoindolinderivat
FI55070C (fi) Anordning foer rensning av vaegar
IT948412B (it) Ossadiazolidin 3 5 dioni
FI54324B (fi) Tvaettmedelkomposition saerskilt foer tvaettning av polyestertyg
FI55063C (fi) Foerfarande foer framstaellning av cellulosamassa av vaextfiberaemne
FI54159C (fi) Foerfarande foer vaermeoxidering av avlut
FI53695C (fi) Munstycksplatta foer en elektrisk smaeltningsanordning foer framstaellning av oorganiska fibrer saerskilt glasfibrer